BDH Industries Limited (BOM:524828)
359.25
+1.10 (0.31%)
At close: May 26, 2026
BDH Industries Revenue
In the fiscal year ending March 31, 2026, BDH Industries had annual revenue of 959.55M INR with 44.27% growth. BDH Industries had revenue of 290.32M in the quarter ending March 31, 2026, with 62.91% growth.
Revenue
959.55M
Revenue Growth
+44.27%
P/S Ratio
2.20
Revenue / Employee
8.57M
Employees
112
Market Cap
2.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 959.55M | 294.46M | 44.27% |
| Mar 31, 2025 | 665.08M | -193.23M | -22.51% |
| Mar 31, 2024 | 858.31M | 113.74M | 15.28% |
| Mar 31, 2023 | 744.57M | 50.63M | 7.30% |
| Mar 31, 2022 | 693.94M | 119.42M | 20.79% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bal Pharma | 3.09B |
| Parnax Lab | 2.28B |
| Ambalal Sarabhai Enterprises | 2.02B |
| Everest Organics | 1.89B |
| Gennex Laboratories | 1.52B |
| Kerala Ayurveda | 1.45B |
| Astonea Labs | 1.17B |
| Oxygenta Pharmaceutical | 1.13B |